Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: Rationale, design, and baseline characteristics of patients in the losartan heart failure survival study-ELITE II

References

Page 1

	Year	Citations
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction Marc A. Pfeffer, Eugene Braunwald, Lemuel A. Moyé, New England Journal of Medicine	1992	5.9K
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Bertram Pitt, Robert Segal, Felipe A Martinez, The Lancet Heart FailureCardiorenal SyndromesCardiovascular DiseaseGeriatricsLosartan Versus Captopril	1997	1.7K
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials R. Garg JAMA HypertensionHeart FailureAce InhibitorsCardiovascular DiseaseAntihypertensive Therapy	1995	1.5K
Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction Albert L. Waldo, A. John Camm, Hans deRuyter, The Lancet Heart FailureCardiovascular DiseaseLeft Ventricular DysfunctionMyocardial InfarctionCoronary Artery Disease	1996	1.4K
QT dispersion and sudden unexpected death in chronic heart failure Craig Barr, A. A O Naas, Monica R. Freeman, The Lancet Heart FailureCardiogenic ShockCardiovascular DiseaseQt DispersionCardiac Care	1994	770
Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular Dysfunction Claude R. Benedict, Brent J. Shelton, David E. Johnstone, Circulation	1996	355
The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens Hanne Elming European Heart Journal	1998	320
Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart Failure Milton Packer, Madeline Yushak, Norma Medina New England Journal of Medicine	1986	298
Reasons for Underuse of Angiotensin-Converting Enzyme Inhibitors in Patients With Heart Failure and Left Ventricular Dysfunction Bradley A. Bart, Wendy A. Gattis, Susan J. Diem, The American Journal of Cardiology Angiotensin-converting Enzyme InhibitorsHypertensionHeart FailureCardiomyopathyCardiorenal Syndromes	1997	80
Losartan exerts antiarrhythmic activity independent of angiotensin II receptor blockade in simulated ventricular ischemia and reperfusion. G. Neil Thomas, Gregory R. Ferrier, Susan E. Howlett Journal of Pharmacology and Experimental Therapeutics	1996	43

Page 1